These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38865440)

  • 1. Non-hemorrhagic imaging markers of cerebral amyloid angiopathy in memory clinic patients.
    Costa AS; Albrecht M; Reich A; Nikoubashman O; Schulz JB; Reetz K; Pinho J
    Alzheimers Dement; 2024 Jul; 20(7):4792-4802. PubMed ID: 38865440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
    Charidimou A; Boulouis G; Frosch MP; Baron JC; Pasi M; Albucher JF; Banerjee G; Barbato C; Bonneville F; Brandner S; Calviere L; Caparros F; Casolla B; Cordonnier C; Delisle MB; Deramecourt V; Dichgans M; Gokcal E; Herms J; Hernandez-Guillamon M; Jäger HR; Jaunmuktane Z; Linn J; Martinez-Ramirez S; Martínez-Sáez E; Mawrin C; Montaner J; Moulin S; Olivot JM; Piazza F; Puy L; Raposo N; Rodrigues MA; Roeber S; Romero JR; Samarasekera N; Schneider JA; Schreiber S; Schreiber F; Schwall C; Smith C; Szalardy L; Varlet P; Viguier A; Wardlaw JM; Warren A; Wollenweber FA; Zedde M; van Buchem MA; Gurol ME; Viswanathan A; Al-Shahi Salman R; Smith EE; Werring DJ; Greenberg SM
    Lancet Neurol; 2022 Aug; 21(8):714-725. PubMed ID: 35841910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Amyloid Angiopathy in Patients with Cognitive Impairment: Cerebrospinal Fluid Biomarkers.
    Rothenberg KG; Bekris L; Leverenz JB; Wu J; Lee J; Statsevych V; Ruggieri P; Jones SE
    Dement Geriatr Cogn Disord; 2024; 53(5):248-254. PubMed ID: 38889704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
    J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
    J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in histopathological markers of cerebral amyloid angiopathy and related hemorrhage.
    Koemans EA; Perosa V; Freeze WM; Lee H; Kozberg MG; Coughlan GT; Buckley RF; Wermer MJ; Greenberg SM; van Veluw SJ
    Int J Stroke; 2024 Oct; 19(8):947-956. PubMed ID: 38703035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-β42 over Amyloid Positron Emission Tomography.
    Pyun JM; Kang MJ; Baek SJ; Lee K; Park YH; Kim SY
    J Prev Alzheimers Dis; 2024; 11(4):1041-1046. PubMed ID: 39044515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.
    Shams S; Martola J; Charidimou A; Larvie M; Granberg T; Shams M; Kristoffersen-Wiberg M; Wahlund LO
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.
    Charidimou A; Martinez-Ramirez S; Reijmer YD; Oliveira-Filho J; Lauer A; Roongpiboonsopit D; Frosch M; Vashkevich A; Ayres A; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    JAMA Neurol; 2016 Aug; 73(8):994-1001. PubMed ID: 27366898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population.
    Shams S; Martola J; Charidimou A; Cavallin L; Granberg T; Shams M; Forslin Y; Aspelin P; Kristoffersen-Wiberg M; Wahlund LO
    Neurology; 2016 Sep; 87(11):1110-7. PubMed ID: 27534713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
    Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
    J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy.
    Charidimou A; Ni J; Martinez-Ramirez S; Vashkevich A; Ayres A; Rosand J; Gurol EM; Greenberg SM; Viswanathan A
    Cerebrovasc Dis; 2016; 41(3-4):156-62. PubMed ID: 26751369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
    J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    van Harten TW; Heijmans A; van Rooden S; Wermer MJH; van Osch MJP; Kuijf HJ; van Veluw SJ; Greenberg SM; van Buchem MA; van der Grond J; van Walderveen MAA
    J Alzheimers Dis; 2022; 90(1):381-388. PubMed ID: 36120778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
    Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
    Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Boston Criteria v2.0/v1.5 for Cerebral Amyloid Angiopathy to Predict Recurrent Intracerebral Hemorrhage.
    Fandler-Höfler S; Gattringer T; Enzinger C; Werring DJ
    Stroke; 2023 Jul; 54(7):1901-1905. PubMed ID: 37264913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.
    Boulouis G; Charidimou A; Jessel MJ; Xiong L; Roongpiboonsopit D; Fotiadis P; Pasi M; Ayres A; Merrill ME; Schwab KM; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    Neurology; 2017 Feb; 88(9):878-884. PubMed ID: 28130469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
    J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study.
    Switzer AR; Charidimou A; McCarter S; Vemuri P; Nguyen AT; Przybelski SA; Lesnick TG; Rabinstein AA; Brown RD; Knopman DS; Petersen RC; Jack CR; Reichard RR; Graff-Radford J
    Neurology; 2024 May; 102(10):e209386. PubMed ID: 38710005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.